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Identity 
This translocation should not be confused with the 
t(5;12)(q33;p13) ETV6/PDGFRB, found so far in 
chronic myelomonocytic leukemia (3 cases, Golub et 
al., 1994; Wlodarska et al., 1995; Crescenzi et al., 
2007), atypical chronic myeloproliferative disorder (1 
case, Nadal et al., 2006), chronic eosinophilic leukemia 
(1 case, Erben et al., 2010), and acute myeloid 
leukemia (1 case, Tokita et al., 2007). However, 26 
cases of t(5;12)(q33;p13) at least have been described 
in the litterature (see Mitelman database), most of them 
without molecular studies. 
Clinics and pathology 
Disease 
Acute myeloid leukemia 
Epidemiology 
One case to date with ascertainment of a breakpoint in 
ERC1, a M5a-AML in a 36-year-old male patient. 
Evolution 




The t(5;12) was the sole anomaly. 






Although the translocation is described as 
t(5;12)(q33;p13), PDGFRB sits in 5q32. 
Protein 
Membrane receptor that binds specifically to PDGFB 






Involved in exocytosis. Ubiquitously expressed. In 
nerve terminals, ERC1/ELKS and ERC2/CAST are 
localized in the active zone (AZ), a region beneath the 
presynaptic plasma membrane. 
They interact with other AZ proteins (RIM1, Piccolo, 
Bassoon, and Munc13-1), forming a large molecular 
complex, and are involved in the release of 
neurotransmitters (review in Hida and Ohtsuka, 2010). 




5' ERC1 - 3' PDGFRB 
Transcript 




Fuses the CAZ (cytomatrix at the active zone) complex 
of ERC1 to the tyrosine kinase domain of PDGFRB. 
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